Hemodialysis Market by Type (Conventional [3 times per week], Daily [6 days a week], and Nocturnal [3-6 nights per week]), Product & Service (Equipment, Consumable, Drug, and Service), and End User (In-center dialysis and Home dialysis) - Global Opportunity Analysis and Industry Forecast, 2018-2025
- ALL2646827
- 240 Pages
- July 2018
- Healthcare
Hemodialysis is a medical procedure used to remove waste from the blood of patients with chronic or acute kidney failure. The waste removal helps to maintain electrolyte balance in the patient’s body. The procedure works similar to an artificial kidney by filtering the blood through a device called the hemodialyzer. It also prevents accumulation of salts and wastes in blood, which may lead to poisoning. The global hemodialysis market was valued at $71,501 million in 2017 and is expected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
The global hemodialysis market is expected to grow, owing to the increase in geriatric population and incidence of renal diseases, especially end stage renal disease (ESRD). In addition, increase in funding for improved dialysis products and services, rise in incidence of diabetes and hypertension, and shortage of kidneys for transplantation are expected to further propel the market growth. Although the hemodialysis market continues to grow, certain factors hamper the growth of this market. The complications and risks associated with the procedure of hemodialysis, such as severe anemia and fluid overload, drag the market growth. In addition, product recalls in recent years also have a negative impact over the market growth. Conversely, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global hemodialysis market.
The hemodialysis market is segmented on the basis of type, product and service, end user, and region. On the basis of type, it is categorized into conventional (3 times per week), daily (6 days a week), and nocturnal (3‐6 nights per week). According to product and service, it is categorized into equipment, consumable, drug, and service.
By end user, it is divided into in-center dialysis and home dialysis. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global hemodialysis market.
- Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
- An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By type
- Conventional (3 times per week)
- Daily (6 days a week)
- Nocturnal (3‐6 nights per week)
By product and service
- Equipment
- Consumable
- Drug
- Service
By end user
- In-center dialysis
- Home dialysis
By region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
The list of key players operating in this market includes:
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International, Inc.
- Cantel Medical Corp.
- DaVita, Inc.
- Diaverum
- Fresenius Medical Care AG & Co. KGaA
- Nikkiso Co., Ltd.
- Nipro Corporation
- NxStage Medical, Inc.
The other players included in the value chain analysis (and not included in the report) include:
- Gambro
- Satellite Healthcare, Inc.
- MEDIVATORS, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Clinical trials
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in funding for improved dialysis products and services
3.4.1.2. Increase in the number of ESRD patients
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Risks and complications associated with dialysis
3.4.2.2. Product recall
3.4.3. Opportunities
3.4.3.1. Technological advancements leading to better adoption
3.4.3.2. Growth opportunities in emerging economies
3.4.4. Impact Analyses
3.5. Patent analysis (2013-2018)
3.5.1. Patent analysis, by year
CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Equipment
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Dialysis Machines
4.2.3.1. Market size and forecast
4.2.4. Hemodialysis Water Treatment Systems
4.2.4.1. Market size and forecast
4.2.5. Others hemodialysis equipment
4.2.5.1. Market size and forecast
4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country
4.3. Consumables
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.3. Dialyzers
4.3.3.1. Market size and forecast
4.3.4. Catheters
4.3.4.1. Market size and forecast
4.3.5. Other hemodialysis consumables
4.3.5.1. Market size and forecast
4.3.6. Market size and forecast, region
4.3.7. Market analysis, by country
4.4. Drugs
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Services
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE
5.1. Overview
5.2. Conventional hemodialysis
5.2.1. Market analysis, by country
5.3. Short daily hemodialysis/daily hemodialysis
5.3.1. Market analysis, by country
5.4. Nocturnal hemodialysis
5.4.1. Market analysis, by country
CHAPTER 6: HEMODIALYSIS MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. hemodialysis market, by type
6.2.2.1.2. U.S. hemodialysis market, by product and service
6.2.2.1.3. U.S. hemodialysis market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada hemodialysis market, by type
6.2.2.2.2. Canada hemodialysis market, by product and service
6.2.2.2.3. Canada hemodialysis market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico hemodialysis market, by type
6.2.2.3.2. Mexico hemodialysis market, by product and service
6.2.2.3.3. Mexico hemodialysis market, by end user
6.2.3. North America hemodialysis market, by type
6.2.4. North America hemodialysis market, by product and service
6.2.5. North America hemodialysis market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany hemodialysis market, by type
6.3.2.1.2. Germany hemodialysis market, by product and service
6.3.2.1.3. Germany hemodialysis market, by end user
6.3.2.2. France
6.3.2.2.1. France hemodialysis market, by type
6.3.2.2.2. France hemodialysis market, by product and service
6.3.2.2.3. France hemodialysis market, by end user
6.3.2.3. UK
6.3.2.3.1. UK hemodialysis market, by type
6.3.2.3.2. UK hemodialysis market, by product and service
6.3.2.3.3. UK hemodialysis market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy hemodialysis market, by type
6.3.2.4.2. Italy hemodialysis market, by product and service
6.3.2.4.3. Italy hemodialysis market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain hemodialysis market, by type
6.3.2.5.2. Spain hemodialysis market, by product and service
6.3.2.5.3. Spain hemodialysis market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe hemodialysis market, by type
6.3.2.6.2. Rest of Europe hemodialysis market, by product and service
6.3.2.6.3. Rest of Europe hemodialysis market, by end user
6.3.3. Europe hemodialysis market, by type
6.3.4. Europe hemodialysis market, by product and service
6.3.5. Europe hemodialysis market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan hemodialysis market, by type
6.4.2.1.2. Japan hemodialysis market, by product and service
6.4.2.1.3. Japan hemodialysis market, by end user
6.4.2.2. China
6.4.2.2.1. China hemodialysis market, by type
6.4.2.2.2. China hemodialysis market, by product and service
6.4.2.2.3. China hemodialysis market, by end user
6.4.2.3. India
6.4.2.3.1. India hemodialysis market, by type
6.4.2.3.2. India hemodialysis market, by product and service
6.4.2.3.3. India hemodialysis market, by end user
6.4.2.4. Australia
6.4.2.4.1. Australia hemodialysis market, by type
6.4.2.4.2. Australia hemodialysis market, by product and service
6.4.2.4.3. Australia hemodialysis market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea hemodialysis market, by type
6.4.2.5.2. South Korea hemodialysis market, by product and service
6.4.2.5.3. South Korea hemodialysis market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific hemodialysis market, by type
6.4.2.6.2. Rest of Asia-Pacific hemodialysis market, by product and service
6.4.2.6.3. Rest of Asia-Pacific hemodialysis market, by end user
6.4.3. Asia-Pacific hemodialysis market, by type
6.4.4. Asia-Pacific hemodialysis market, by product and service
6.4.5. Asia-Pacific hemodialysis market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil hemodialysis market, by type
6.5.2.1.2. Brazil hemodialysis market, by product and service
6.5.2.1.3. Brazil hemodialysis market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia hemodialysis market, by type
6.5.2.2.2. Saudi Arabia hemodialysis market, by product and service
6.5.2.2.3. Saudi Arabia hemodialysis market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa hemodialysis market, by type
6.5.2.3.2. South Africa hemodialysis market, by product and service
6.5.2.3.3. South Africa hemodialysis market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA hemodialysis market, by type
6.5.2.4.2. Rest of LAMEA hemodialysis market, by product and service
6.5.2.4.3. Rest of LAMEA hemodialysis market, by end user
6.5.3. LAMEA hemodialysis market, by type
6.5.4. LAMEA hemodialysis market, by product and service
6.5.5. LAMEA hemodialysis market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Asahi Kasei Corporation.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. Braun Melsungen AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Baxter International Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Cantel Medical Corp.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. DaVita Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Diaverum.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product Portfolio
7.6.4. Key strategic moves and developments
7.7. Fresenius Medical Care AG & Co. KGaA
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Nikkiso Co., Ltd.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Nipro Corporation
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. NxStage Medical, Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2017-2025 ($MILLION)
TABLE 02. HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 03. HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. GLOBAL HEMODIALYSIS CONSUMABLES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 05. HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. HEMODIALYSIS DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. HEMODIALYSIS SERVICES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 09. CONVENTIONAL HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. SHORT DAILY/ DAILY HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. NOCTURNAL HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 12. HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 13. NORTH AMERICA HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 14. U.S. HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 15. U.S. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 16. U.S. HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 17. CANADA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 18. CANADA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 19. CANADA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 20. MEXICO HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 21. MEXICO HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 22. MEXICO HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 23. NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 25. NORTH AMERICA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. EUROPE HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 27. GERMANY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 28. GERMANY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 29. GERMANY HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 30. FRANCE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 31. FRANCE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 32. FRANCE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 33. UK HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 34. UK HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 35. UK HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 36. ITALY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. ITALY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 38. ITALY HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 39. SPAIN HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 40. SPAIN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 41. SPAIN HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 42. REST OF EUROPE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 43. REST OF EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 44. REST OF EUROPE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 45. EUROPE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 46. EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 47. EUROPE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 48. ASIA-PACIFIC HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 49. JAPAN HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. JAPAN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 51. JAPAN HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 52. CHINA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 53. CHINA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 54. CHINA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 55. INDIA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. INDIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 57. INDIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 58. ITALY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 59. AUSTRALIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 60. AUSTRALIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 61. SOUTH KOREA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 62. SOUTH KOREA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 63. SOUTH KOREA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 67. ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 68. ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 69. ASIA-PACIFIC HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 70. LAMEA HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 71. BRAZIL HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 72. BRAZIL HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 73. BRAZIL HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 74. SAUDI ARABIA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 75. SAUDI ARABIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 76. SAUDI ARABIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 77. SOUTH AFRICA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 78. SOUTH AFRICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 79. SOUTH AFRICA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. REST OF LAMEA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 81. REST OF LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 82. REST OF LAMEA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 83. LAMEA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 84. LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 85. LAMEA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 86. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 87. ASAHI KASEI: OPERATING SEGMENTS
TABLE 88. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 89. B. BRAUN: COMPANY SNAPSHOT
TABLE 90. B. BRAUN: OPERATING SEGMENTS
TABLE 91. B. BRAUN: PRODUCT PORTFOLIO
TABLE 92. BAXTER: COMPANY SNAPSHOT
TABLE 93. BAXTER: BUSINESS UNITS
TABLE 94. CANTEL MEDICAL: COMPANY SNAPSHOT
TABLE 95. CANTEL MEDICAL: OPERATING SEGMENTS
TABLE 96. CANTEL MEDICAL: PRODUCT PORTFOLIO
TABLE 97. DAVITA: COMPANY SNAPSHOT
TABLE 98. DAVITA: OPERATING SEGMENTS
TABLE 99. DAVITA: PRODUCT PORTFOLIO
TABLE 100. DIAVERUM: COMPANY SNAPSHOT
TABLE 101. DIAVERUM: PRODUCT PORTFOLIO
TABLE 102. FRESENIUS: COMPANY SNAPSHOT
TABLE 103. FRESENIUS: OPERATING SEGMENTS
TABLE 104. FRESENIUS: PRODUCT PORTFOLIO
TABLE 105. NIKKISO : COMPANY SNAPSHOT
TABLE 106. NIKKISO: OPERATING SEGMENTS
TABLE 107. NIKKISO: PRODUCT PORTFOLIO
TABLE 108. NIPRO: COMPANY SNAPSHOT
TABLE 109. NIPRO: OPERATING SEGMENTS
TABLE 110. NXSTAGE: COMPANY SNAPSHOT
TABLE 111. NXSTAGE: OPERATING SEGMENTS
TABLE 112. NXSTAGE: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. HEMODIALYSIS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018**
FIGURE 06. CLINICAL TRIALS IN HEMODIALYSIS MARKET, BY REGION*
FIGURE 07. CLINICAL TRIALS IN HEMODIALYSIS MARKET, NORTH AMERICA*
FIGURE 08. IMPACT ANALYSES, GLOBAL HEMODIALYSIS MARKET
FIGURE 09. PATENTS REGISTERED/APPROVED IN THE WORLD, 2013-2018
FIGURE 10. PATENTS ANALYSIS BY YEAR, 2013 THROUGH 2017
FIGURE 11. HEMODIALYSIS MACHINES MARKET, 2017- 2025 ($MILLION)
FIGURE 12. HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, 2017- 2025 ($MILLION)
FIGURE 13. OTHER HEMODIALYSIS EQUIPMENT MARKET 2017-2025 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. DIALYZERS MARKET 2017-2025 ($MILLION)
FIGURE 16. CATHETERS MARKET 2017-2025 ($MILLION)
FIGURE 17. OTHER HEMODIALYSIS CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HEMODIALYSIS CONSUMABLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF HEMODIALYSIS DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF CONVENTIONAL HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. SHORT DAILY/ DAILY HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. NOCTURNAL HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. NET SALES, 2015-2017 ($MILLION)
FIGURE 25. : NET SALES BY SEGMENT, 2017 (%)
FIGURE 26. ASAHI KASEI: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 27. NET SALES, 2015-2017 ($MILLION)
FIGURE 28. B. BRAUN: NET SALES BY DIVISION, 2017 (%)
FIGURE 29. B. BRAUN: NET SALES BY REGION, 2017 (%)
FIGURE 30. NET SALES, 2015-2017 ($MILLION)
FIGURE 31. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2017 (%)
FIGURE 32. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. NET SALES, 2015-2017 ($MILLION)
FIGURE 34. CANTEL MEDICAL: NET SALES BY SEGMENT, 2017 (%)
FIGURE 35. CANTEL MEDICAL: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 36. NET SALES, 2015-2017 ($MILLION)
FIGURE 37. DAVITA: NET SALES BY SEGMENT, 2017 (%)
FIGURE 38. FRESENIUS: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. FRESENIUS: NET SALES BY SEGMENT, 2017 (%)
FIGURE 40. FRESENIUS: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 41. NET SALES, 2015-2017 ($MILLION)
FIGURE 42. NIKKISO: NET SALES BY BUSINESS SEGMENT, 2017 (%)
FIGURE 43. NIKKISO: NET SALES BY REGION, 2017 (%)
FIGURE 44. NET SALES, 2015-2017 ($MILLION)
FIGURE 45. NIPRO: NET SALES BY SEGMENT, 2017 (%)
FIGURE 46. NIPRO: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 47. REVENUES, 2015-2017 ($MILLION)
FIGURE 48. NXSTAGE: REVENUES BY SEGMENT, 2017 (%)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
